Welcome to our dedicated page for Salesforce Com news (Ticker: CRM), a resource for investors and traders seeking the latest updates and insights on Salesforce Com stock.
News about Salesforce, Inc. (NYSE: CRM) focuses on its activities as an AI-powered enterprise cloud and CRM provider, along with its role in helping organizations become what it calls Agentic Enterprises. Company announcements highlight new AI agents, platform enhancements, customer deployments, acquisitions, and capital allocation decisions that shape how Salesforce technology is used across industries.
Recent releases describe the general availability of a reimagined Slackbot as a personal agent for work inside Slack, designed to use conversational and customer context to help people find information, organize work, create content, and orchestrate workflows. Other news covers deployments of Agentforce 360 and Data 360 at institutions such as DeVry University, where AI agents support adult learners with 24/7 assistance, streamlined enrollment, and personalized guidance.
Salesforce news also details how public sector and life sciences organizations use its platforms. The U.S. Department of Transportation is reported to be expanding its use of Salesforce and Agentforce to modernize complaint management, safety inspections, interstate data sharing, and federal grantmaking. In life sciences, companies such as Novartis and AstraZeneca are described as selecting Agentforce Life Sciences to unify healthcare professional engagement and customer interactions using AI and data harmonization.
In addition, Salesforce publishes Cyber Week commerce data based on aggregated activity across digital storefronts powered by Agentforce Commerce, emphasizing the role of AI and agents in influencing sales and handling customer service interactions. Investors and observers can also find updates on dividends, acquisitions such as the completion of the Informatica transaction, and other corporate developments. This news feed provides an ongoing view into how Salesforce’s AI, data, and cloud capabilities are being adopted and expanded across sectors.
Salesforce (NYSE: CRM) announced on October 8, 2025 that Vonage will deploy Data Cloud and Agentforce to unify enterprise data and scale AI-driven customer experiences. Vonage will integrate Data Cloud with Service Cloud, Sales Cloud and MuleSoft to create a single source of truth, provide secure real-time insights, and power AI agents that automate routine tasks.
Agentforce will handle profile updates, case management, and health-score tracking while AI agents analyze full customer histories to surface issues and next steps. The partnership aims to accelerate Vonage’s transformation to an "Agentic Enterprise" and deepen a nearly two-decade strategic relationship; Vonage is described as a top-rated Salesforce partner on the AppExchange.
Haleon (LSE/NYSE:HLN) announced on October 8, 2025 it selected Salesforce Life Sciences Cloud for Customer Engagement, Data Cloud, and Agentforce to support its global sales organisation. The AI-powered rollout will cover Haleon's 4,500-strong sales force to improve engagement with pharmacies and healthcare professionals and to deliver data-driven insights on consumer demographics, shopping trends, and point-of-sale marketing.
Haleon will serve as a design partner to influence product availability, shelf-life management, promotions, and inventory features for consumer health use cases. The company said the change aims to reduce administrative time for reps and enable more bespoke activation plans for customers worldwide.
Salesforce (NYSE: CRM), the leading AI CRM company, has announced its upcoming Investor Day scheduled for October 15, 2025. The event will be held in conjunction with Dreamforce in San Francisco, CA, starting at 1:00 p.m. PT / 4:00 p.m. ET.
Investors and interested parties can access the event through a live webcast on Salesforce's investor relations website. The presentation materials and an on-demand replay will be made available at www.salesforce.com/investor after the event.
Salesforce (NYSE: CRM), the leading AI CRM company, has announced its board of directors has declared a quarterly cash dividend of $0.416 per share. The dividend will be paid on October 9, 2025, to shareholders who are on record as of September 17, 2025.
Salesforce (NYSE:CRM) reported outstanding Q2 fiscal 2026 results, with revenue reaching $10.2 billion, up 10% year-over-year. The company demonstrated strong performance across key metrics, with subscription & support revenue growing 11% to $9.7 billion and current remaining performance obligation reaching $29.4 billion.
Notable achievements include a GAAP operating margin of 22.8% and non-GAAP operating margin of 34.3%. The company returned $2.6 billion to shareholders, including $2.2 billion in share repurchases and $399 million in dividends. Salesforce also announced a $20 billion increase to its share repurchase program, bringing the total authorized to $50 billion.
The company's AI initiatives showed remarkable growth, with Data Cloud and AI annual recurring revenue exceeding $1.2 billion, up 120% year-over-year. Salesforce has closed over 12,500 Agentforce deals, with more than 6,000 being paid implementations.
Salesforce (NYSE: CRM) has granted equity awards to former Convergence.ai employees following its acquisition. Under the 2014 Inducement Equity Incentive Plan, the company issued two types of restricted stock units (RSUs):
The first grant consists of 37,486 RSUs to 20 employees, vesting over four years with 25% vesting after the first year and the remainder quarterly. The second grant includes 12,739 RSUs to 14 employees, vesting over three years in quarterly installments. All recipients are non-executive employees, and vesting is contingent on continued employment.
Salesforce (NYSE: CRM), the leading AI CRM company, has scheduled its second quarter fiscal 2026 earnings release for September 3, 2025, after market close. The company will host a conference call with the investment community at 2:00 PM PT / 5:00 PM ET on the same day. Investors can access both the live webcast and replay through Salesforce's Investor Relations website.
BetterInvesting Magazine has selected Salesforce (NYSE: CRM) as its "Stock to Study" and Accenture PLC (NYSE: ACN) for fundamental review in its October 2025 issue. The Editorial Advisory and Securities Review Committee, composed of certified financial analysts, will provide detailed analysis of both companies.
For Salesforce, investors can access comprehensive fundamental data including sales, earnings, pre-tax profit, and return on equity through the National Association of Investors Corp.'s platform. The committee suggests Accenture may present an opportunity from an undervalued perspective.
Salesforce (NYSE: CRM) has announced the appointment of two new directors to its Board: Amy Chang, an accomplished technology executive and AI entrepreneur, and David Kirk, a pioneering computer scientist and former NVIDIA chief scientist.
The appointments, effective immediately, are strategically aimed at strengthening Salesforce's technical expertise and innovation leadership in the agentic AI era. CEO Marc Benioff emphasized that these additions will help unlock the potential of human-AI collaboration and digital labor through Agentforce and the company's unified platform.
Lead Independent Director Arnold Donald highlighted that these appointments align with Salesforce's deliberate approach to board composition, bringing technical depth at a crucial time when AI is reshaping business landscapes.
Salesforce (NYSE: CRM) announced a collaboration with UChicago Medicine to implement Agentforce for Health, its AI-powered digital labor platform. The integration aims to enhance patient experience by providing 24/7 automated support for non-clinical tasks.
The system will handle various patient requests including prescription refills, appointment scheduling, insurance verification, and providing real-time logistical support. This implementation is designed to improve operational efficiency by automating routine inquiries, allowing staff to focus on more complex patient needs requiring personal attention.
FAQ
What is the current stock price of Salesforce Com (CRM)?
What is the market cap of Salesforce Com (CRM)?
